| Literature DB >> 30906458 |
Jie Xiao1, Jian Zhou1, Hui Liang2, Fumin Liu3, Chenchen Xu4, Li Liang1.
Abstract
Impact of hemostatic methods, electrocoagulation versus suture, on ovarian reserve and fertility in laparoscopic ovarian cystectomy was investigated. Eighty patients with bilateral ovarian cysts who underwent laparoscopic ovarian cystectomy were randomly divided into 2 groups based on the hemostatic methods: 40 in suture group and another 40 in electrocoagulation group. Blood samples were drawn from all patients at roughly three time points: Before the surgery, 1 month and 6 months after the surgery. Radioimmunoassay was performed to measure the serum levels of follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2) and anti-Mullerian hormone (AMH). Moreover, the vaginal ultrasound examination was performed to obtain the ovarian size, peak systolic velocity (PSV) of ovarian stromal blood flow, and antral follicle count (AFC). In terms of postoperative ovarian reserve, the levels of E2 and AMH slightly decreased while the FSH level slightly increased in the suture group at both 1 and 6 months after surgery. In the electrocoagulation group, however, the levels of E2 and AMH decreased significantly while the FSH level increased significantly at 1 month after surgery. Six months after surgery, these levels all returned slightly showing some recovery of ovarian reserve. In comparison between the suture group and the electrocoagulation group, the differences in levels of E2, FSH and AMH were all statistically significant at both 1 and 6 months after surgery (P<0.05). Six months after surgery, the differences in AFC and PSV between the suture group and the electrocoagulation group were statistically significant (P<0.05). In laparoscopic ovarian cystectomy, hemostatic electrocoagulation had a more negative impact on ovarian reserve than hemostatic suture. The use of electrocoagulation for hemostasis should be minimized during the operation, and the suture method should be adopted for hemostasis and shaping of the ovarian wound.Entities:
Keywords: fertility; hemostatic electrocoagulation; hemostatic suture; laparoscopic ovarian cystectomy; ovarian reserve
Year: 2019 PMID: 30906458 PMCID: PMC6425261 DOI: 10.3892/etm.2019.7259
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
General clinical records of patients with ovarian cysts in the suture and the electrocoagulation group (n=80).
| Groups | ||||
|---|---|---|---|---|
| General clinical record | Suture | Electroco- agulation | t value | P-value |
| Age, years Cyst diameter, cm | 28.59±4.22 | 28.25±3.90 | 0.357 | 0.797 |
| Left side | 5.75±0.74 | 5.93±0.93 | −0.858 | 0.547 |
| Right side | 5.82±0.97 | 5.63±0.91 | 0.86 | 0.557 |
Types of ovarian cysts determined by postoperative pathological tests in the suture and the electrocoagulation group (n=80).
| Groups | ||||
|---|---|---|---|---|
| Type of ovarian cyst | Suture | Electroco- agulation | χ2 | P-value |
| Teratoma | 13 | 16 | ||
| Endometrioma | 13 | 13 | 0.67 | 0.724 |
| Epidermoid cyst | 14 | 11 | ||
Reproductive hormone levels of patients in the two groups before and after surgery (n=40).
| Before surgery | 1 month after surgery | 6 months after surgery | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hormone level | Suture group | Electrocoagulation group | t value | P-value | Suture group | Electrocoagulation group | t value | P-value | Suture group | Electrocoagulation group | t value | P-value |
| FSH, mIU/ml | 6.442±1.631 | 6.688±1.590 | −0.684 | 0.496 | 8.712±3.185 | 10.800±2.768 | −3.129 | 0.002 | 7.820±2.617 | 10.008±2.653 | −3.713 | <0.001 |
| LH, mIU/ml | 6.649±2.356 | 7.412±2.543 | −1.391 | 0.168 | 7.169±2.179 | 7.804±2.188 | −1.301 | 0.197 | 6.971±2.253 | 7.681±2.306 | −1.393 | 0.168 |
| E2, pg/ml | 63.736±31.154 | 61.711±27.479 | 0.308 | 0.759 | 55.173±25.166 | 41.929±22.811 | 2.188 | 0.032 | 55.807±26.862 | 44.776±19.632 | 2.097 | 0.039 |
| AMH, ng/ml | 3.318±0.760 | 3.568±0.824 | −1.410 | 0.163 | 2.521±0.786 | 2.046±0.551 | 3.133 | 0.002 | 2.751±0.632 | 2.450±0.672 | 2.069 | 0.042 |
FSH, follicle stimulating hormone; LH, luteinizing hormone; E2, estradiol; AMH, anti-Mullerian hormone.
Results of AFC and PSV by vaginal ultrasonography before and after surgery in the two groups (n=80).
| Before surgery | 6 months after surgery | |||||||
|---|---|---|---|---|---|---|---|---|
| Groups | Groups | |||||||
| Ultrasound results | Suture | Electroco- agulation | t value | P-value | Suture | Electroco- agulation | t value | P-value |
| AFC, number | 8.450±2.218 | 8.330±2.018 | 2.264 | 0.793 | 7.950±2.012 | 7.130±1.505 | 2.076 | 0.041 |
| PSV, m/s | 0.123±0.044 | 0.121±0.041 | 0.183 | 0.856 | 0.121±0.047 | 0.098±0.035 | 2.422 | 0.018 |
Maximum ovarian diameters after surgery by vaginal ultrasonography in the two groups (n, %).
| Groups | ||||
|---|---|---|---|---|
| Diameter | Suture | Electroco- agulation | χ2 | P-value |
| >2 cm | 35 (87.5%) | 31 (77.5%) | 1.385 | 0.239 |
| ≤2 cm | 5 (12.5%) | 9 (22.5%) | ||
Postoperative pregnancy odds of patients with childbearing desire (n, %).
| Groups | ||||
|---|---|---|---|---|
| Diameter | Suture | Electroco- agulation | χ2 | P-value |
| Yes | 17 (56.7%) | 15 (51.7%) | 0.290 | 0.590 |
| No | 13 (43.3%) | 14 (48.2%) | ||